European Journal of Pharmacology 1991: Vol 199 Index

15 Pages·1991·4.8 MB·English

European Journal of Pharmacology, 199 (1991) 393-396
© 1991 Elsevier Science Publishers B.V. 0014-/2919 /9$039.5 0
Author index
Aas, P., Gaudry-Talarmain, Y.M. and Fonnum, F. Chapal, J., see Hillaire-Buys, D. (199) 309
Effect of AHS5S183 (vesamicol) on cholinergic transmission in Chapelain, B., see Mahe, L. (199) 19
intact airway smooth muscle (199) 357 Cherici, G., see Moroni, F. (199) 227
Ackerman, M., see DeNinno, M.P. (199) 209 Chugh, Y., Chakrabarti, A. and Sharma, P.L.
Alesiani, M., see Moroni, F. (199) 227 Diazepam-atenolol combination antagonizes aminophylline-in-
Andrade, R. duced convulsions and lethality in mice (199) 135
Blockade of neurotransmitter-activated K* conductance by QX- Comini, L., see Cargnoni, A. (199) 165
314 in the rat hippocampus (199) 259 Compton, A.M., see Gardiner, S.M. (199) 375
Ardid, D., see Eschalier, A. (199) 119 Condorelli, E., see Cargnoni, A. (199) 165
Artigas, F., see Ortiz, J. (199) 335 Cook, J.A., see Li, E.J. (199) 221
Artman, L., see DeNinno, M.P. (199) 209 Correa, S.G., Bianco, I.D., Riera, C.M. and Fidelio, G.D.
Ashton, S., see Li, E.J. (199) 221 Anti-inflammatory effect of gangliosides in the rat hindpaw edema
Asin, K.E., see DeNinno, M.P. (199) 209 test (199) 93
Aumaitre, O., see Eschalier, A. (199) 119 Cox, R.F. and Waszczak, B.L.
Autoradiography of dopamine D, receptors using [*H]YM-
Bartholini, G., see Porcella, A. (199) 267 09151-2 (199) 103
Bast, A., see Van der Vliet, A. (199) 153 Curzon, P., see DeNinno, M.P. (199) 209
Bednarz, L., see DeNinno, M.P. (199) 209 Cuthbert, A.W., see Pickles, R.J. (199) 77
Bennett, T., see Gardiner, S.M. (199) 375
Berendsen, H.H.G. and Broekkamp, C.L.E. De Garavilla, L., see Silver, P.J. (199) 141
Age dependence of 5-methoxytryptamine-induced hindlimb De Giuli, F., see Cargnoni, A. (199) 165
scratching in rats (199) 107 Delpon, E., see Pérez-Vizcaino, F. (199) 43
Bhandare, P.N., Rataboli, P.V. and Diniz D’Souza, R.S. De Montis, G., Devoto, P., Giorgi, G., Tagliamonte, A. and Gessa,
Dual action of clonidine on ethanol-induced gastric lesions: is the G.L.
imidazoline-preferring receptor involved? (199) 243 Ethanol, at micromolar concentrations, increases the affinity of
Bhatt, R., see DeNinno, M.P. (199) 209 [>H]MK-801 binding in rat brain (199) 139
Bianco, I.D., see Correa, S.G. (199) 93 DeNinno, M.P., Schoenleber, R., MacKenzie, R., Britton, D.R..,
Bjork, L., Lindgren, S., Hacksell, U. and Lewander, T. Asin, K.E., Briggs, C., Trugman, J.M., Ackerman, M., Artman,
(S)-UH-301 antagonizes (R)-8-OH-DPAT-induced cardiovascular L., Bednarz, L., Bhatt, R., Curzon, P., Gomez, E., Kang, C.H..,
effects in the rat (199) 367 Stittsworth, J. and Kebabian, J.W.
Blanchard, J.-C., see BOhme, G.A. (199) 379 A68930: a potent agonist selective for the dopamine D, receptor
Bloom, S.R., see Kanse, S.M. (199) 99 (199) 209
Bohme, G.A., Bon, C., Stutzmann, J.-M., Doble, A. and Blanchard, Devoto, P., see De Montis, G. (199) 139
J.-C. Dijkstra, D., see Timmerman, W. (199) 145
Possible involvement of nitric oxide in long-term potentiation Diniz D’Souza, R.S., see Bhandare, P.N. (199) 243
(199) 379 Doble, A., see BOhme, G.A. (199) 379
Bon, C., see BOhme, G.A. (199) 379 Duchéne-Marullaz, P., see Eschalier, A. (199) 119
Boraso, A., see Cargnoni, A. (199) 165 Dyer, D.C., see Zhang, L. (199) 179
Bose, C., see Gardiner, S.M. (199) 375
Braquet, P., see Szilvassy, Z. (199) 383 Egan, M.F., Karoum, F. and Wyatt, R.J.
Briggs, C., see DeNinno, M.P. (199) 209 Effects of acute and chronic clozapine and haloperidol adminis-
Britton, D.R., see DeNinno, M.P. (199) 209 tration on 3-methoxytyramine accumulation in rat prefrontal cor-
Broekkamp, C.L.E., see Berendsen, H.H.G. (199) 107 tex, nucleus accumbens and striatum (199) 191
Buchholz, R.A., see Silver, P.J. (199) 141 Elsworth, J.D., see Taylor, J.R. (199) 389
Bult, H., Fret, H.R.L., Jordaens, F.H. and Herman, A.G. Eschalier, A., Aumaitre, O., Ardid, D., Fialip, J. and Duchéne-
Dipyridamole potentiates the anti-aggregating and vasodilator Marullaz, P.
activity of nitric oxide (199) 1 Long-lasting antinociceptive effect of RC-160, a somatostatin
Burch, R.M., see Noronha-Blob, L. (199) 387 analog, in mice and rats (199) 119
Cargnoni, A., Boraso, A., Comini, L., De Giuli, F., Condorelli, E., Fage, D., see Porcella, A. (199) 267
Pasini, E. and Ferrari, R. Feller, D.R., see Shams, G. (199) 315
Role of timing of administration in the cardioprotective effect of Feng, D.M., see Maggi, C.A. (199) 127
iloprost, a stable prostacyclin mimetic (199) 165 Ferrari, R., see Cargnoni, A. (199) 165
Carla, V., see Moroni, F. (199) 227 Fialip, J., see Eschalier, A. (199) 119
Carron, R., see Pérez-Vizcaino, F. (199) 43 Fidelio, G.D., see Correa, S.G. (199) 93
Carter, C., see Porcella, A. (199) 267 Folkers, K., see Maggi, C.A. (199) 127
Chakrabarti, A., see Chugh, Y. (199) 135 Fonnum, F., see Aas, P. (199) 357
394
Forgione, A., see Sigala, S. (199) 247 Effect of NZ-107 on late-phase airway responses and airway
Foulkes, R., see Gardiner, S.M. (199) 375 hyperreactivity in guinea pigs (199) 271
Fret, H.R.L., see Bult, H. (199) 1 Iwamura, S., see Hagiwara, M. (199) 69
Furukawa, T., see Katsuragi, T. (199) 303
Johnson, K.M., see Yi, S.-J. (199) 185
Galli, A., see Moroni, F. (199) 227 Jordaens, F.H., see Bult, H. (199) 1
Gardiner, S.M., Compton, A.M., Kemp, P.A., Bennett, T., Bose, C., Jr.ain, R.W.K., see Maisonneuve, I.M. (199) 35
Foulkes, R. and Hughes, B.
Human a-calcitonin gene-related peptide (CGRP)-(8-37), but not
Kang, C.H., see DeNinno, M.P. (199) 209
-(28-37), inhibits carotid vasodilator effects of human a-CGRP in
Kanse, S.M., Takahashi, K., Warren, J.B., Ghatei, M. and Bloom,
vivo (199) 375
S.R.
Gargouil, Y.-M., see Mahe, L. (199) 19
Glucocorticoids induce endothelin release from vascular smooth
Garratt, J.C., Kidd, E.J., Wright, I.K. and Marsden, C.A.
muscle cells but not endothelial cells (199) 99
Inhibition of 5-hydroxytryptamine neuronal activity by the 5-HT
Karoum, F., see Egan, M.F. (199) 191
agonist, DOI (199) 349
Katsuragi, T., Kuratomi, L., Sato, C. and Furukawa, T.
Gaudry-Talarmain, Y.M., see Aas, P. (199) 357
Hyperreactivity of a@,-adrenoceptors, but not of P,-purinocep-
Gessa, G.L., see De Montis, G. (199) 139
tors, in vas deferens of spontaneously hypertensive rats (199) 303
Ghatei, M., see Kanse, S.M. (199) 99
Kebabian, J.W., see DeNinno, M.P. (199) 209
Giachetti, A., see Lecci, A. (199) 201
Kemp, P.A., see Gardiner, S.M. (199) 375
Gifford, A.N., see Yi, S.-J. (199) 185
Kidd, E.J., see Garratt, J.C. (199) 349
Giordano, J.
King, K.A., see McCall, R.B. (199) 263
Analgesic profile of centrally administered 2-methylserotonin
Klabunde, R.E., Ritger, R.C. and Helgren, M.C.
against acute pain in rats (199) 233
Cardiovascular actions of inhibitors of endothelium-derived relax-
Giorgi, G., see De Montis, G. (199) 139
ing factor (nitric oxide) formation/ release in anesthetized dogs
Giuliani, S., see Lecci, A. (199) 201
(199) 51
Glick, S.D., see Maisonneuve, I.M. (199) 35
Kobayashi, M., see Hagiwara, M. (199) 69
Gomez, E., see DeNinno, M.P. (199) 209
Koltai, M., see Szilvassy, Z. (199) 383
Gottesmann, C., see Romettino, S. (199) 371
Kuratomi, L., see Katsuragi, T. (199) 303
Grol, C.J., see Timmerman, W. (199) 145
Hacksell, U., see Bjork, L. (199) 367 Lafontan, M., see Langin, D. (199) 291
Hagiwara, M., Mikami, T., Iwamura, S., Miyazawa, K., Kobayashi, Langin, D., Portillo, M.P., Saulnier-Blache, J.-S. and Lafontan, M.
Coexistence of three B-adrenoceptor subtypes in white fat cells of
M. and Miyasaka, K.
Effects of TZI-41127, a novel selective 5-lipoxygenase inhibitor, various mammalian species (199) 291
on A23187-induced pleurisy in rats (199) 69 Lawrence, M.S., see Taylor, J.R. (199) 389
Hall, J.M., Mitchell, D. and Morton, I.K.M. Lazdunski, M., see Romettino, S. (199) 371
Neurokinin receptors in the rabbit iris sphincter characterised by Lecci, A., Giuliani, S., Santicioli, P., Rovero, P., Maggi, C.A. and
novel agonist ligands (199) 9 Giachetti, A.
Halushka, P.V., see Li, E.J. (199) 221 Intracerebroventricular administration of endothelins: effects on
Hamada, A., see Shams, G. (199) 315 the supraspinal micturition reflex and blood pressure in the
anaesthetized rat (199) 201
Harris, L.T., see McCall, R.B. (199) 263
Hatake, K., see Wakabayashi, I. (199) 115 Lewander, T., see BjOrk, L. (199) 367
Helgren, M.C., see Klabunde, R.E. (199) 51 Li, E.J., Cook, J.A., Ashton, S., Wise, W.C. and Halushka, P.V.
Effect of the LTD, receptor antagonist LY203647 on endotoxic
Heller, J., see Miller, L.G. (199) 111
shock sequelae in the rat (199) 221
Hembrough, F.B., see Zhang, L. (199) 179
Herman, A.G., see Bult, H. (199) 1 Liebmann, C., Schnittler, M., Stewart, J.M. and Reimann, S.
Heuer, H.O. Antagonist binding reveals two heterogenous B, bradykinin re-
Inhibition of active anaphylaxis in mice and guinea pigs by the ceptors in rat myometrial membranes (199) 363
new hetrazepinoic PAF antagonist bepafant (WEB 2170) (199) Lindgren, S., see Bjork, L. (199) 367
157 Long, J.P., see Ma, S. (199) 27
Hibi, M., see Iwama, T. (199) 271 Loubatiéres-Mariani, M.-M., see Hillaire-Buys, D. (199) 309
Lowe, V.C., see Noronha-Blob, L. (199) 387
Hillaire-Buys, D., Chapal, J., Petit, P. and Loubatiéres-Mariani,
M.-M.
Dual regulation of pancreatic vascular tone by Px and Psy
Ma, S. and Long, J.P.
purinoceptor subtypes (199) 309 Effects of nitroglycerin on release, synthesis and metabolism of
Hisa, H., see Tomura, Y. (199) 255 norepinephrine and activation of tyrosine hydroxylase in guinea-
Hjorth, S. pigs (199) 27
Single-dose 8-OH-DPAT pretreatment does not induce tachyphy- MacKenzie, R., see DeNinno, M.P. (199) 209
laxis to the 5-HT release-reducing effect of 5-HT,, autoreceptor Maggi, C.A., Patacchini, R., Feng, D.M. and Folkers, K.
agonists (199) 237 Activity of spantide I and II at various tachykinin receptors and
Hoffman, P.L., see Szab6, G. (199) 131 NK-2 tachykinin receptor subtypes (199) 127
Horn, A.S., see Timmerman, W. (199) 145 Maggi, C.A., see Lecci, A. (199) 201
Hughes, B., see Gardiner, S.M. (199) 375 Mahe, L., Chapelain, B., Gargouil, Y.-M. and Neliat, G.
Characterization of B-adrenoceptor subtypes and indications for
Isla, M., see Zhang, L. (199) 179 two cell populations in isolated bovine mesenteric lymphatic
Iwama, T., Shikada, K.-i., Yamamoto, A., Sakashita, M., Hibi, M. vessels (199) 19
and Tanaka, S. Mailman, R.B., see Taylor, J.R. (199) 389
Maisonneuve, I.M., Jr.ain, R.W.K. and Glick, S.D. Radziszewski, W., see Salvemini, D. (199) 15
Interactions between ibogaine, a potential anti-addictive agent, Rand, M.J., see Vo, P.A. (199) 123
and morphine: an in vivo microdialysis study (199) 35 Rataboli, P.V., see Bhandare, P.N. (199) 243
Marsden, C.A., see Garratt, J.C. (199) 349 Redmond, Jr., D.E., see Taylor, J.R. (199) 389
McCall, R.B., Harris, L.T. and King, K.A. Reid, J.J., see Vo, P.A. (199) 123
Sympatholytic action of yohimbine mediated by 5-HT,, receptors ReiBmann, S., see Liebmann, C. (199) 363
(199) 263 Riera, C.M., see Correa, S.G. (199) 93
McFalls, E.O., see Sassen, L.M.A. (199) 61 Ritger, R.C., see Klabunde, R.E. (199) 51
Mikami, T., see Hagiwara, M. (199) 69 Rizzonelli, P., see Sigala, S. (199) 247
Miller, D.D., see Shams, G. (199) 315 Romettino, S., Lazdunski, M. and Gottesmann, C.
Miller, L.G. and Heller, J. Anticonvulsant and sleep-waking influences of riluzole in a rat
Chronic exposure to a benzodiazepine partial agonist does not model of absence epilepsy (199) 371
alter GABA, receptor function in cultured neurons (199) 111 Roth, R.H., see Taylor, J.R. (199) 389
Missale, C., see Sigala, S. (199) 247 Rovero, P., see Lecci, A. (199) 201
Mitchell, D., see Hall, J.M. (199) 9
Miyasaka, K., see Hagiwara, M. (199) 69
Sakamoto, K., see Wakabayashi, I. (199) 115
Miyazawa, K., see Hagiwara, M. (199) 69
Sakashita, M., see Iwama, T. (199) 271
Mocaér, E., see Ortiz, J. (199) 335
Salvemini, D., Radziszewski, W., Mollace, V., Moore, A., Willoughby,
Mollace, V., see Salvemini, D. (199) 15 D. and Vane, J.
Moore, A., see Salvemini, D. (199) 15
Diphenylene iodonium, an inhibitor of free radical formation,
Mori, F., see Moroni, F. (199) 227
inhibits platelet aggregation (199) 15
Moroni, F., Alesiani, M., Galli, A., Mori, F., Pecorari, R., Carla, V., Santicioli, P., see Lecci, A. (199) 201
Cherici, G. and Pellicciari, R.
Sassen, L.M.A., Van der Zande, J., McFalls, E.O. and Verdouw,
Thiokynurenates: a new group of antagonists of the glycine P.D.
modulatory site of the NMDA receptor (199) 227 Cardiovascular profile of the new dihydropyridine derivative
Morton, I.K.M., see Hall, J.M. (199) 9 S12968 (199) 61
Sato, C., see Katsuragi, T. (199) 303
Neliat, G., see Mahe, L. (199) 19 Satoh, S., see Tomura, Y. (199) 255
Nichols, D.E., see Taylor, J.R. (199) 389 Saulnier-Blache, J.-S., see Langin, D. (199) 291
Noronha-Blob, L., Lowe, V.C., Weitzberg, M. and Burch, R.M. Scatton, B., see Porcella, A. (199) 267
NPC 15669 enhances survival and reverses leukopenia in endo- Schnittler, M., see Liebmann, C. (199) 363
toxin-treated mice (199) 387 Schoenleber, R., see DeNinno, M.P. (199) 209
Schultheiss, A., see Szabo, B. (199) 325
Shams, G., Venkataraman, B.V., Hamada, A., Miller, D.D., Patil,
Ortiz, J.. Mocaér, E. and Artigas, F.
P.N. and Feller, D.R.
Effects of the antidepressant drug tianeptine on plasma and
Diversity of the pharmacological actions of some tolazoline ana-
platelet serotonin concentrations in the rat (199) 335
logues in human platelets and rat aorta (199) 315
Sharma, P.L., see Chugh, Y. (199) 135
Pagani, E.D., see Silver, P.J. (199) 141 Shikada, K.-i., see Iwama, T. (199) 271
Pasini, E., see Cargnoni, A. (199) 165 Sigala, S., Rizzonelli, P., Zanelli, E., Forgione, A., Missale, C. and
Patacchini, R., see Maggi, C.A. (199) 127 Spano, P.F.
Patil, P.N., see Shams, G. (199) 315 Low doses of |l-sulpiride down-regulate striatal and cortical
Pecorari, R., see Moroni, F. (199) 227 dopamine receptors and B-adrenoceptors (199) 247
Pellicciari, R., see Moroni, F. (199) 227 Silver, P.J., Pagani, E.D., De Garavilla, L., VanAller, G.S., Volberg,
Pérez-Vizcaino, F., Carrén, R., Delpén, E. and Tamargo, J. M.L., Pratt, P.F. and Buchholz, R.A.
Effects of (S)-nafenodone, a new antidepressant, in isolated Reversal or nitroglycerin tolerance by the cGMP phosphodi-
guinea-pig atrial and ventricular muscle fibres (199) 43 esterase inhibitor zaprinast (199) 141
Peterson, S.L. Soltis, E.E., see Piascik, M.T. (199) 279
Anticonvulsant drug potentiation by glycine in maximal elec- Spano, P.F., see Sigala, S. (199) 247
troshock seizures is mimicked by D-serine and antagonized by Sparks, M.S., see Piascik, M.T. (199) 279
7-chlorokynurenic acid (199) 341 Starke, K., see Szabo, B. (199) 325
Petit, P., see Hillaire-Buys, D. (199) 309 Stewart, J.M., see Liebmann, C. (199) 363
Piascik, M.T., Sparks, M.S., Pruitt, T.A. and Soltis, E.E. Stittsworth, J., see DeNinno, M.P. (199) 209
Evidence for a complex interaction between the subtypes of the Stoelwinder, H., see Timmerman, W. (199) 145
a,-adrenoceptor (199) 279 Stutzmann, J.-M., see BOhme, G.A. (199) 379
Pickles, R.J. and Cuthbert, A.W. Szabo, B., Schultheiss, A. and Starke, K.
Relation of anion secretory activity to intracellular Ca?* in The noradrenaline uptake inhibitor, (+ )-oxaprotiline, but not the
response to lysylbradykinin and histamine in a cultured human inactive enantiomer, (—)-oxaprotiline, inhibits sympathetic nerve
colonic epithelium (199) 77 activity in the rabbit: involvement of adrenoceptors (199) 325
Porcella, A., Fage, D., Voltz, C., Carter, C., Scatton, B. and Szabo, G., Tabakoff, B. and Hoffman, P.L.
Bartholini, G. Comparative effects of arginine vasopressin, [pGlu*,Cyt°® Jarginine
Difluoromethyl ornithine protects against the neurotoxic effects vasopressin-(4-9) and nerve growth factor on maintenance of
of intrastriatally administered N-methyl-D-aspartate in vivo (199) functional tolerance to ethanol in mice (199) 131
267 Szekeres, L., see Szilvassy, Z. (199) 383
Portillo, M.P., see Langin, D. (199) 291 Szilvassy, Z., Koltai, M., Szekeres, L., Tarrade, T. and Braquet, P.
Pratt, P.F., see Silver, P.J. (199) 141 Effect of cicletanine on overpacing-induced ST-segment elevation
Pruitt, T.A., see Piascik, M.T. (199) 279 in conscious rabbits. A comparison with verapamil (199) 383
396
Tabakoff, B., see Szab6, G. (199) 131 Vo, P.A., Reid, J.J. and Rand, M.J.
Tagliamonte, A., see De Montis, G. (199) 139 Endothelial nitric oxide attenuates vasoconstrictor responses to
Takahashi, K., see Kanse, S.M. (199) 99 nerve stimulation and noradrenaline in the rat tail artery (199)
Tamargo, J., see Pérez-Vizcaino, F. (199) 43 123
Tanaka, S., see Iwama, T. (199) 271 Volberg, M.L., see Silver, P.J. (199) 141
Tarrade, T., see Szilvassy, Z. (199) 383 Voltz, C., see Porcella, A. (199) 267
Taylor, J.R., Lawrence, M.S., Redmond, Jr., D.E., Elsworth, J.D.,
Roth, R.H., Nichols, D.E. and Mailman, R.B. Wakabayashi, I., Hatake, K. and Sakamoto, K.
Dihydrexidine, a full dopamine D, agonist, reduces MPTP-in- Mechanisms of ex vivo aortic hypocontractility in endotoxemic rat
duced parkinsonism in monkeys (199) 389 (199) 115
Tepper, P.G., see Timmerman, W. (199) 145 Warren, J.B., see Kanse, S.M. (199) 99
Timmerman, W., Tepper, P.G., Dijkstra, D., Stoelwinder, H., Grol, Waszczak, B.L., see Cox, R.F. (199) 103
C.J., Westerink, B.H.C. and Horn, AS. Weitzberg, M., see Noronha-Blob, L. (199) 387
Enantiomers of monohydroxy-2-aminotetralin derivatives and Westerink, B.H.C., see Timmerman, W. (199) 145
their activity at dopamine autoreceptors as studied by brain Willoughby, D., see Salvemini, D. (199) 15
dialysis (199) 145 Wise, W.C., see Li, E.J. (199) 221
Tomura, Y., Yamagata, T., Hisa, H. and Satoh, S. Wright, I.K., see Garratt, J.C. (199) 349
Effects of atrial natriuretic peptide on adrenergically induced Wyatt, R.J., see Egan, M.F. (199) 191
norepinephrine release and vasoconstriction in the dog kidney
(199) 255 Yamagata, T., see Tomura, Y. (199) 255
Trugman, J.M., see DeNinno, M.P. (199) 209 Yamamoto, A., see Iwama, T. (199) 271
Yi, S.-J., Gifford, A.N. and Johnson, K.M.
VanAller, G.S., see Silver, P.J. (199) 141 Effect of cocaine and 5-HT, receptor antagonists on 5-HT-in-
Van der Vliet, A. and Bast, A. duced [*H]dopamine release from rat striatal synaptosomes (199)
Hydrogen peroxide reduces B-adrenoceptor function in the rat 185
small intestine (199) 153
Van der Zande, J., see Sassen, L.M.A. (199) 61 Zanelli, E., see Sigala, S. (199) 247
Vane, J., see Salvemini, D. (199) 15 Zhang, L., Dyer, D.C., Hembrough, F.B. and Isla, M.
Venkataraman, B.V., see Shams, G. (199) 315 Effect of R(—)2,5-dimethoxy-4-methylamphetamine on uterine
Verdouw, P.D., see Sassen, L.M.A. (199) 61 and umbilical blood flow in conscious pregnant sheep (199) 179
European Journal of Pharmacology, 199 (1991) 397-406
© 1991 Elsevier Science Publishers B.V. 0014-/2919 /9$039.5 0
Key word index
Absence epilepsy B-Adrenoceptor subtypes
Spike-wave discharges; Anticonvulsant; Sleep-waking; (Rat) (Romet- B-Adrenoceptors (atypical); Lipolysis; Adipocytes; BRL 37344;
tino, S. (199) 371) Phenylethanolaminotetralines (Langin, D. (199) 291)
Acetylcholine Affinity labels
AH 5183; Vesamicol; Airways; Vesicles (Aas, P. (199) 357) Antiaggregatory mechanisms; Tolazoline analogues; Platelets (hu-
man); Aorta (rat); a@5-Adrenoceptors; Non-adrenoceptor mecha-
nisms; Isothiocyanato analogue; Chloroethylclonidine; (Antagonists)
Action potential
(Shams, G. (199) 315)
(S)-Nafenodone; Atria; Ventricle (Pérez-Vizcaino, F. (199) 43)
AH 5183
Adenocarcinoma (colonic)
Acetylcholine; Vesamicol; Airways; Vesicles (Aas, P. (199) 357)
Anion secretion; Epithelium; Ca** concentration (intracellular); Ly-
sylbradykinin; Histamine (Pickles, R.J. (199) 77)
A23187-induced pleurisy
TZI-41127; Leukotrienes; Prostaglandin E,; (HPLC); (Rat)
Adipocytes (Hagiwara, M. (199) 69)
B-Adrenoceptors (atypical); Lipolysis; B-Adrenoceptor subtypes;
BRL 37344; Phenylethanolaminotetralines (Langin, D. (199) 291) Airway hyperreactivity
NZ-107 (4-bromo-5-(3-ethoxy-4-methoxybenzylamino)-3(2H)-pyri-
a ,-Adrenoceptors dazinone); Airway responses (late-phase); (Guinea-pig) (Iwama, T.
a,-Adrenoceptor subtypes; Smooth muscle regulation (vascular) (199) 271)
(Piascik, M.T. (199) 279)
Airway responses (late-phase)
NZ-107 (4-bromo-5-(3-ethoxy-4-methoxybenzylamino)-3(2H)-pyri-
Contraction; Noradrenaline release; Noradrenaline content; ATP;
dazinone); Airway hyperreactivity; (Guinea-pig) (Iwama, T. (199)
Vas deferens; Spontaneously hypertensive rat (SHR) (Katsuragi, T.
(199) 303) 271)
Airways
a,-Adrenoceptors
Acetylcholine; AH 5183; Vesamicol; Vesicles (Aas, P. (199) 357)
Ethanol lesion; Clonidine; Imidazoline preferring receptor (Bhan-
dare, P.N. (199) 243)
Alkalinization (intracellular)
Endotoxin; Smooth muscle (vascular); Phosphatidylinositol
Sympathetic nerve activity; 5-HT,, receptors; Yohimbine; Spiperone
(Wakabayashi, I. (199) 115)
(McCall, R.B. (199) 263)
5-Amino valeryl-[L-Pro?,N-Me-Leu!°S]P -
Antiaggregatory mechanisms; Tolazoline analogues; Platelets (hu- Neurokinin receptors; Iris (rabbit); Tachykinins; NK-1 receptors;
man); Aorta (rat); Non-adrenoceptor mechanisms; Isothiocyanato NK-3 receptors; Peptidase inhibitors; [Lys*,Gly -R-y-lactam,
analogue; Chloroethylclonidine; Affinity labels; (Antagonists) (Shams, Leu’ INKA-(3-10); Senktide; (7-11) (Hall, J.M. (199) 9)
G. (199) 315)
Analgesia
B-Adrenoceptors RC-160 (D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Trp-N5H) ; Somato-
Lymphatic vessels (bovine); Contractions (Mahe, L. (199) 19) statin analogs; (Mouse); (Rat) (Eschalier, A. (199) 119)
2-Methylserotonin; 5-HT, receptors; Pain; Spinal cord (Giordano, J.
Oxidative stress; Inflammation; Intestine; Hydrogen peroxide; (Re-
(199) 233)
ceptors) (Van der Vliet, A. (199) 153)
Anaphylaxis
l-Sulpiride; Depression; Dopamine D, receptors; Frontal cortex
PAF (platelet-activating factor, PAF-acether); PAF antagonist
(Sigala, S. (199) 247)
bepafant (WEB 2170) (Heuer, H.O. (199) 157)
fB-Adrenoceptors (atypical)
Anion secretion
Lipolysis; $-Adrenoceptor subtypes; Adipocytes; BRL 37344; Epithelium; Ca?* concentration (intracellular); Adenocarcinoma
Phenylethanolaminotetralines (Langin, D. (199) 291) (colonic); Lysylbradykinin; Histamine (Pickles, R.J. (199) 77)
a ,-Adrenoceptor subtypes ANP (atrial natriuretic polypeptide)
a,-Adrenoceptors; Smooth muscle regulation (vascular) (Piascik, Kidney; Norepinephrine release; Vasoconstriction (Tomura, Y. (199)
M.T. (199) 279) 255)
398
Antiaggregatory mechanisms Atria
Tolazoline analogues; Platelets (human); Aorta (rat); a,-Adrenocep- (S)-Nafenodone; Ventricle; Action potential (Pérez-Vizcaino, F. (199)
tors; Non-adrenoceptor mechanisms; Isothiocyanato analogue; 43)
Chloroethylclonidine; Affinity labels; (Antagonists) (Shams, G. (199)
315) Autoradiography
[7HJYM-09151-2; Dopamine D, receptors; Benzamides (substituted);
Anticonvulsant Basal ganglia; Brain (rat) (Cox, R.F. (199) 103)
Spike-wave discharges; Absence epilepsy; Sleep-waking; (Rat)
(Romettino, S. (199) 371) Basal ganglia
[>H]YM-09151-2; Autoradiography; Dopamine D, receptors; Benza-
Anticonvulsants mides (substituted); Brain (rat) (Cox, R.F. (199) 103)
Glycine; D-Serine; 7-Chlorokynurenic acid; Electroshock (maximal);
(Rat) (Peterson, S.L. (199) 341) Behaviour
Hindlimb scratching; 5-HT,p receptors; Ontogeny; (Rat) (Berend-
Antidepressant drugs sen, H.H.G. (199) 107)
Noradrenaline spillover rate; Sympathoinhibition; Sympathetic nerve
activity; Uptake inhibition; (Anaesthetized rabbit) (Szabo, B. (199) Benzamides (substituted)
325) [SH]YM-09151-2; Autoradiography; Dopamine D, receptors; Basal
ganglia; Brain (rat) (Cox, R.F. (199) 103)
Antidepressants
Tianeptine; 5-HT uptake; Plasma; Platelets; 5-HT synthesis (Ortiz, J.
Benzodiazepines
(199) 335) Ro 16-6028; GABA, receptors; (Partial agonist) (Miller, L.G. (199)
111)
Antiepileptics
Convulsions; Atenolol (Chugh, Y. (199) 135)
Binding profiles
Bradykinin; Myometrium (rat); B, receptor antagonists; B, receptor
Anti-inflammatory action
subtypes (Liebmann, C. (199) 363)
Gangliosides; Phospholipase A; Carrageenin; Dextran (Correa, S.G.
(199) 93)
Blood flow (regional)
Dihydropyridine; $12968; Haemodynamics (systemic); Myocardial
Anti-platelet agents
blood flow (regional); Myocardial contractile function; (Pig) (Sassen,
Platelet aggregation; Diphenylene iodonium; Free radicals; Endothe-
L.M.A. (199) 61)
lial cells (Salvemini, D. (199) 15)
Blood pressure
Aorta (rabbit)
Endothelins; Micturition; (Intracerebroventricular); (Rat) (Lecci, A.
Platelet aggregation; Dipyridamole; Nitric oxide (NO); Endothelium;
(199) 201)
Organic nitrates (Bult, H. (199) 1)
Hematocrit; Leukopenia; Lymphopenia; Neutropenia (Li, E.J. (199)
Aorta (rat)
221)
Antiaggregatory mechanisms; Tolazoline analogues; Platelets (hu-
man); a,-Adrenoceptors; Non-adrenoceptor mechanisms; Isothio-
8-OH-DPAT (8-hydroxy-2-(dipropylamino)tetralin); UH-301; Heart
cyanato analogue; Chloroethylclonidine; Affinity labels; (Antagonists)
rate; 5-HT,, receptor antagonists (Bjork, L. (199) 367)
(Shams, G. (199) 315)
Blood pressure (dog)
L-Arginine
EDRF (endothelium-derived relaxing factor); N©-Monomethyl-L- EDRF (endothelium-derived relaxing factor); L-Arginine; N°&-
Monomethyl-L-arginine; N°-Nitro-L-arginine; Vasoconstriction;
arginine; N°-Nitro-L-arginine; Vasoconstriction; Blood pressure
Phenylephrine; Indomethacin; Coronary blood flow (Klabunde, R.E.
(dog); Phenylephrine; Indomethacin; Coronary blood flow (Klabunde,
R.E. (199) 51) (199) 51)
[pGlu*,Cyt®]arginine vasopressin-(4-9) BMY 7378
5-HT release; 5-HT,, autoreceptors; Desensitisation; 5-HT,, recep-
Nerve growth factor; Ethanol tolerance (effect on); [Arg® ]vasopressin
(AVP) (Szabo, G. (199) 131) tor agonists; 8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tetralin);
Ipsapirone; CNS (central nervous system); (Rat) (Hjorth, S. (199)
A 68930 ((1R,3S)-1-aminomethyI]-5,6-dihydroxy-3-phenylisochroman ) 237)
Dopamine D, receptors (DeNinno, M.P. (199) 209)
Bradykinin
Atenolol Myometrium (rat); B, receptor antagonists; Binding profiles; B,
Convulsions; Antiepileptics (Chugh, Y. (199) 135) receptor subtypes (Liebmann, C. (199) 363)
ATP Brain (rat)
Contraction; Noradrenaline release; Noradrenaline content; a,- [HJYM-09151-2; Autoradiography; Dopamine D, receptors; Benza-
Adrenoceptors; Vas deferens; Spontaneously hypertensive rat (SHR) mides (substituted); Basal ganglia (Cox, R.F. (199) 103)
(Katsuragi, T. (199) 303)
B, receptor antagonists
Vasoconstriction; Vasodilatation; P, purinoceptors; Pancreas (iso- Bradykinin; Myometrium (rat); Binding profiles; B, receptor sub-
lated); (Rat) (Hillaire-Buys, D. (199) 309) types (Liebmann, C. (199) 363)
B, receptor subtypes Convulsions
Bradykinin; Myometrium (rat); B, receptor antagonists; Binding Atenolol; Antiepileptics (Chugh, Y. (199) 135)
profiles (Liebmann, C. (199) 363)
Coronary blood flow
BRL 37344 EDRF (endothelium-derived relaxing factor); L-Arginine; N°-
B-Adrenoceptors (atypical); Lipolysis; B-Adrenoceptor subtypes; Monomethyl-L-arginine; N&-Nitro-L-arginine; Vasoconstriction;
Adipocytes; Phenylethanolaminotetralines (Langin, D. (199) 291) Blood pressure (dog); Phenylephrine; Indomethacin (Klabunde, R.E.
(199) 51)
Ca’** concentration (intracellular)
Anion secretion; Epithelium; Adenocarcinoma (colonic); Lysyl- Depression
bradykinin; Histamine (Pickles, R.J. (199) 77) l-Sulpiride; Dopamine D, receptors; B-Adrenoceptors; Frontal cor-
tex (Sigala, S. (199) 247)
Cardioprotection
Iloprost; Ischaemia (myocardial); Reperfusion (myocardial); Prosta- Desensitisation
cyclin (Cargnoni, A. (199) 165) 5-HT release; 5-HT,, autoreceptors; 5-HT,, receptor agonists; 8-
OH-DPAT (8-hydroxy-2-(di-n-propylamino)tetralin); Ipsapirone;
Cardiovascular action BMY 7378; CNS (central nervous system); (Rat) (Hjorth, S. (199)
Nitroglycerin; Norepinephrine; Norepinephrine release; Nore- 237)
pinephrine synthesis; Norepinephrine turnover; Tyrosine hydroxyl-
ase; Langendorff heart; Striatal slices (Ma, S. (199) 27)
Dextran
Gangliosides; Anti-inflammatory action; Phospholipase A,; Car-
Carrageenin rageenin (Correa, S.G. (199) 93)
Gangliosides; Anti-inflammatory action; Phospholipase A,; Dextran
(Correa, S.G. (199) 93)
Dihydropyridine
S$12968; Haemodynamics (systemic); Myocardial blood flow (re-
a -CGRP-(8-37) gional); Myocardial contractile function; Blood flow (regional); (Pig)
Haemodynamics; (Rat) (Gardiner, S.M. (199) 375)
(Sassen, L.M.A. (199) 61)
Chloroethylclonidine
Diphenylene iodonium
Antiaggregatory mechanisms; Tolazoline analogues; Platelets (hu-
Platelet aggregation; Free radicals; Endothelial cells; Anti-platelet
man); Aorta (rat); @,-Adrenoceptors; Non-adrenoceptor mecha-
agents (Salvemini, D. (199) 15)
nisms; Isothiocyanato analogue; Affinity labels; (Antagonists) (Shams,
G. (199) 315)
Dipyridamole
Aorta (rabbit); Platelet aggregation; Nitric oxide (NO); Endothelium;
7-Chlorokynurenic acid
Organic nitrates (Bult, H. (199) 1)
Glycine; D-Serine; Anticonvulsants; Electroshock (maximal); (Rat)
(Peterson, S.L. (199) 341)
DOI (1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane)
Dorsal raphe; Frontal cortex; Neuronal firing; 5-HT release (Garratt,
Cicletanine
J.C. (199) 349)
Verapamil; ST segment elevation; (Frequency loading); (Conscious
rabbit) (Szilvassy, Z. (199) 383)
DOM (2,5-dimethoxy-4-methylamphetamine)
5-HT receptors; Uterine artery; Umbilical artery; (Pregnant sheep)
Clonidine
(Zhang, L. (199) 179)
Ethanol lesion; a,-Adrenoceptors; Imidazoline preferring receptor
(Bhandare, P.N. (199) 243)
Dopamine
Ibogaine; Morphine; Microdialysis; Striatum; Nucleus accumbens;
Clozapine
Prefrontal cortex (Maisonneuve, I.M. (199) 35)
Neuroleptics (chronic); Haloperidol; 3-Methoxytyramine (Egan, M.F.
(199) 191)
Dopamine D, receptor agonists
CNS (central nervous system) Dopamine release; Microdialysis; Striatum; N-0437 (2-(N-propyl-N-
5-HT release; 5-HT,, autoreceptors; Desensitisation; 5-HT,, recep- 2-thienylethylamino)-5-hydroxytetralin; N-0438 (2-(N-propyl-N-2-
thienylethylamino)-7-hydroxytetralin); 7-OH-DPAT (7-hydroxy-2-
tor agonists; 8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tetralin);
Ipsapirone; BMY 7378; (Rat) (Hjorth, S. (199) 237) (N,N-di-n-propylamino)tetralin); PHNO (4-propyl-9-hydroxynaph-
thoxazine); (Stereoisomers) (Timmerman, W. (199) 145)
Cocaine
Dopamine release; Dopamine uptake; 5-HT uptake; 5-HT receptors Dopamine D, receptors
A 68930 ((1R,3S)-1-aminomethyl-5,6-dihydroxy-3-phenylisochroman)
(Yi, S.-J. (199) 185)
(DeNinno, M.P. (199) 209)
Contraction
Noradrenaline release; Noradrenaline content; a,-Adrenoceptors; Dopamine D, receptors
ATP; Vas deferens; Spontaneously hypertensive rat (SHR) [>H]YM-09151-2; Autoradiography; Benzamides (substituted); Basal
(Katsuragi, T. (199) 303) ganglia; Brain (rat) (Cox, R.F. (199) 103)
Contractions l-Sulpiride; Depression; B-Adrenoceptors; Frontal cortex (Sigala, S.
Lymphatic vessels (bovine); B-Adrenoceptors (Mahe, L. (199) 19) (199) 247)
400
Dopamine release Frontal cortex
Dopamine D, receptor agonists; Microdialysis; Striatum; N-0437 l-Sulpiride; Depression; Dopamine D, receptors; B-Adrenoceptors
(2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin; N-0438 (2- (Sigala, S. (199) 247)
(N-propyl-N-2-thienylethylamino)-7-hydroxytetralin); 7-OH-DPAT
(7-hydroxy-2-(N,N-di-n-propylamino)tetralin); PHNO (4-propyl-9-hy- DOI (1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane); Dorsal
droxynaphthoxazine); (Stereoisomers) (Timmerman, W. (199) 145) raphe; Neuronal firing; 5-HT release (Garratt, J.C. (199) 349)
Dopamine uptake; 5-HT uptake; 5-HT receptors; Cocaine (Yi, S.-J. GABA ,, receptors
(199) 185) Ro 16-6028; Benzodiazepines; (Partial agonist) (Miller, L.G. (199)
111)
Dopamine uptake
Dopamine release; 5-HT uptake; 5-HT receptors; Cocaine (Yi, S.-J. GABA , receptors
(199) 185) QX-314; K* channels; 5-HT,, receptors (Andrade, R. (199) 259)
Dorsal raphe Gangliosides
DOI (1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane); Frontal cor- Anti-inflammatory action; Phospholipase A,; Carrageenin; Dextran
tex; Neuronal firing; 5-HT release (Garratt, J.C. (199) 349) (Correa, S.G. (199) 93)
EDRF (endothelium-derived relaxing factor) Glucocorticoids -
L-Arginine; N°-Monomethyl-L-arginine; N©-Nitro-L-arginine; Endothelin; Endothelium; Smooth muscle (vascular); Hypertension
Vasoconstriction; Blood pressure (dog); Phenylephrine; In- (Kanse, S.M. (199) 99)
domethacin; Coronary blood flow (Klabunde, R.E. (199) 51)
Glutamate receptors
Electroshock (maximal) Kynurenic acid; Glycine receptors; NMDA (N-methyl-D-aspartate);
Glycine; D-Serine; 7-Chlorokynurenic acid; Anticonvulsants; (Rat) Phencyclidine (Moroni, F. (199) 227)
(Peterson, S.L. (199) 341)
Glycine
Endothelial cells D-Serine; 7-Chlorokynurenic acid; Anticonvulsants; Electroshock
Platelet aggregation; Diphenylene iodonium; Free radicals; Anti- (maximal); (Rat) (Peterson, S.L. (199) 341)
platelet agents (Salvemini, D. (199) 15)
Glycine receptors
Endothelin Kynurenic acid; NUDA (N-methyl-D-aspartate); Phencyclidine; Glu-
Glucocorticoids; Endothelium; Smooth muscle (vascular); Hyperten- tamate receptors (Moroni, F. (199) 227)
sion (Kanse, S.M. (199) 99)
Haemodynamics
Endothelins a-CGRP-(8-37); (Rat) (Gardiner, S.M. (199) 375)
Blood pressure; Micturition; (Intracerebroventricular); (Rat) (Lecci,
A. (199) 201) Haemodynamics (systemic)
Dihydropyridine; $12968; Myocardial blood flow (regional); Myocar-
Endothelium dial contractile function; Blood flow (regional); (Pig) (Sassen, L.M.A.
Aorta (rabbit); Platelet aggregation; Dipyridamole; Nitric oxide (NO); (199) 61)
Organic nitrates (Bult, H. (199) 1)
Haloperidol
Endothelin; Glucocorticoids; Smooth muscle (vascular); Hyperten- Neuroleptics (chronic); Clozapine; 3-Methoxytyramine (Egan, M.F.
sion (Kanse, S.M. (199) 99) (199) 191)
Endotoxin Heart rate
Smooth muscle (vascular); Phosphatidylinositol; Alkalinization (in- 8-OH-DPAT (8-hydroxy-2-(dipropylamino)tetralin); UH-301; Blood
tracellular) (Wakabayashi, I. (199) 115) pressure; 5-HT,, receptor antagonists (Bjork, L. (199) 367)
Epithelium Hematocrit
Anion secretion; Ca”* concentration (intracellular); Adenocarci- Blood pressure; Leukopenia; Lymphopenia; Neutropenia (Li, E.J.
noma (colonic); Lysylbradykinin; Histamine (Pickles, R.J. (199) 77) (199) 221)
Ethanol lesion Hindlimb scratching
Clonidine; a@,-Adrenoceptors; Imidazoline preferring receptor 5-HT;p receptors; Ontogeny; Behaviour; (Rat) (Berendsen, H.H.G.
(Bhandare, P.N. (199) 243) (199) 107)
Ethanol tolerance (effect on) Hippocampus (rat)
Nerve growth factor; [pGlu*,Cyt®°]arginine vasopressin-(4-9); Nitric oxide (NO); Long-term potentiation; Synaptic plasticity
[Arg® Wasopressin (AVP) (Szabo, G. (199) 131) (Bohme, G.A. (199) 379)
Free radicals Histamine
Platelet aggregation; Diphenylene iodonium; Endothelial cells; Anion secretion; Epithelium; Ca** concentration (intracellular);
Anti-platelet agents (Salvemini, D. (199) 15) Adenocarcinoma (colonic); Lysylbradykinin (Pickles, R.J. (199) 77)
5-HT,, autoreceptors lloprost
5-HT release; Desensitisation; 5-HT,, receptor agonists; 8-OQH- Cardioprotection; Ischaemia (myocardial); Reperfusion (myocardial);
DPAT (8-hydroxy-2-(di-n-propylamino)tetralin); Ipsapirone; BMY Prostacyclin (Cargnoni, A. (199) 165)
7378; CNS (central nervous system); (Rat) (Hjorth, S. (199) 237)
Imidazoline preferring receptor
5-HT,, receptor agonists Ethanol lesion; Clonidine; a,-Adrenoceptors (Bhandare, P.N. (199)
5-HT release; 5-HT,, autoreceptors; Desensitisation; 8-OH-DPAT 243)
(8-hydroxy-2-(di-n-propylamino)tetralin); Ipsapirone; BMY 7378;
CNS (central nervous system); (Rat) (Hjorth, S. (199) 237)
Indomethacin
EDRF (endothelium-derived relaxing factor); L-Arginine; N°&-
5-HT,, receptor antagonists
Monomethyl-L-arginine; N°-Nitro-L-arginine; Vasoconstriction;
8-OH-DPAT (8-hydroxy-2-(dipropylamino)tetralin); UH-301; Blood
Blood pressure (dog); Phenylephrine; Coronary blood flow
pressure; Heart rate (Bj6rk, L. (199) 367)
(Klabunde, R.E. (199) 51)
5-HT receptors
Inflammation
DOM (2,5-dimethoxy-4-methylamphetamine); Uterine artery; Umbil-
Oxidative stress; B-Adrenoceptors; Intestine; Hydrogen peroxide;
ical artery; (Pregnant sheep) (Zhang, L. (199) 179)
(Receptors) (Van der Vliet, A. (199) 153)
Dopamine release; Dopamine uptake; 5-HT uptake; Cocaine (Yi,
Intestine
S.-J. (199) 185)
Oxidative stress; Inflammation; B-Adrenoceptors; Hydrogen perox-
ide; (Receptors) (Van der Vliet, A. (199) 153)
5-HT,, receptors
QX-314; K* channels; GABA , receptors (Andrade, R. (199) 259)
Ipsapirone
5-HT release; 5-HT,, autoreceptors; Desensitisation; 5-HT,, recep-
Sympathetic nerve activity; Yohimbine; a,-Adrenoceptors; Spiper-
tor agonists; 8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tetralin);
one (McCall, R.B. (199) 263)
BMY 7378; CNS (central nervous system); (Rat) (Hjorth, S. (199)
237)
5-HT,p receptors
Hindlimb scratching; Ontogeny; Behaviour; (Rat) (Berendsen,
H.H.G. (199) 107) Iris (rabbit)
Neurokinin receptors; Tachykinins; NK-1 receptors; NK-3 receptors;
5-HT, receptors Peptidase inhibitors; 6-Amino valeryl-[L-Pro°,N-Me-Leu!°]SP-;
[Lys*,Gly 8-R-y-lactam,Leu’ INKA-(3-10); Senktide; (7-11) (Hall, J.M.
2-Methylserotonin; Pain; Analgesia; Spinal cord (Giordano, J. (199)
233) (199) 9)
5-HT release Ischaemia (myocardial)
5-HT,, autoreceptors; Desensitisation; 5-HT,, receptor agonists; Cardioprotection; Iloprost; Reperfusion (myocardial); Prostacyclin
8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tetralin); Ipsapirone; (Cargnoni, A. (199) 165)
BMY 7378; CNS (central nervous system); (Rat) (Hjorth, S. (199)
237) Isothiocyanato analogue
Antiaggregatory mechanisms; Tolazoline analogues; Platelets (hu-
DOI (1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane); Dorsal man); Aorta (rat); a@>-Adrenoceptors; Non-adrenoceptor mecha-
raphe; Frontal cortex; Neuronal firing (Garratt, J.C. (199) 349) nisms; Chloroethylclonidine; Affinity labels; (Antagonists) (Shams,
G. (199) 315)
5-HT synthesis
Antidepressants; Tianeptine; 5-HT uptake; Plasma; Platelets (Ortiz,
K* channels
J. (199) 335)
QX-314; 5-HT,, receptors; GABA, receptors (Andrade, R. (199)
259)
5-HT uptake
Dopamine release; Dopamine uptake; 5-HT receptors; Cocaine (Yi,
Kidney
S.-J. (199) 185)
ANP (atrial natriuretic polypeptide); Norepinephrine release; Vaso-
constriction (Tomura, Y. (199) 255)
Antidepressants; Tianeptine; Plasma; Platelets; 5-HT synthesis
(Ortiz, J. (199) 335)
Kynurenic acid
Glycine receptors; NMDA (N-methyl-D-aspartate); Phencyclidine;
Hydrogen peroxide
Glutamate receptors (Moroni, F. (199) 227)
Oxidative stress; Inflammation; B-Adrenoceptors; Intestine; (Recep-
tors) (Van der Vliet, A. (199) 153)
Langendorff heart
Nitroglycerin; Norepinephrine; Norepinephrine release; Nore-
Hypertension
pinephrine synthesis; Norepinephrine turnover; Tyrosine hydroxyl-
Endothelin; Glucocorticoids; Endothelium; Smooth muscle (vascu-
ase; Cardiovascular action; Striatal slices (Ma, S. (199) 27)
lar) (Kanse, S.M. (199) 99)
Ibogaine Leukopenia
Morphine; Dopamine; Microdialysis; Striatum; Nucleus accumbens; Hematocrit; Blood pressure; Lymphopenia; Neutropenia (Li, E.J.
Prefrontal cortex (Maisonneuve, I.M. (199) 35) (199) 221)
402
Leukotrienes (S)-Nafenodone
TZI-41127; A23187-induced pleurisy; Prostaglandin E,; (HPLC); Atria; Ventricle; Action potential (Pérez-Vizcaino, F. (199) 43)
(Rat) (Hagiwara, M. (199) 69)
Nerve growth factor
Lipolysis Ethanol tolerance (effect on); [pGlu*,Cyt® Jarginine vasopressin-(4-9);
B-Adrenoceptors (atypical); B-Adrenoceptor subtypes; Adipocytes; [Arg® Wasopressin (AVP) (Szabé, G. (199) 131)
BRL 37344; Phenylethanolaminotetralines (Langin, D. (199) 291)
Neurokinin receptors
Long-term potentiation Iris (rabbit); Tachykinins; NK-1 receptors; NK-3 receptors; Peptidase
Nitric oxide (NO); Hippocampus (rat); Synaptic plasticity (Bohme, inhibitors; 5-Amino valeryl-[L-Pro?,N-Me-Leu!°]SP-; [Lys*,Gly®-R-
G.A. (199) 379) y-lactam,Leu’ INKA-(3-10); Senktide; (7-11) (Hall, J.M. (199) 9)
Lymphatic vessels (bovine)
Neuroleptics (chronic)
B-Adrenoceptors; Contractions (Mahe, L. (199) 19)
Haloperidol; Clozapine; 3-Methoxytyramine (Egan, M.F. (199) 191)
Lymphopenia
Neuronal firing
Hematocrit; Blood pressure; Leukopenia; Neutropenia (Li, E.J. (199)
DOI (1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane); Dorsal
221)
raphe; Frontal cortex; 5-HT release (Garratt, J.C. (199) 349)
Lysylbradykinin
Neurotoxicity
Anion secretion; Epithelium; Ca** concentration (intracellular);
NMDA (N-methyl-D-aspartate); Polyamines; Ornithine decarboxyl-
Adenocarcinoma (colonic); Histamine (Pickles, R.J. (199) 77)
ase; Striatum (rat) (Porcella, A. (199) 267)
3-Methoxytyramine
Neutropenia
Neuroleptics (chronic); Haloperidol; Clozapine (Egan, M.F. (199)
191) Hematocrit; Blood pressure; Leukopenia; Lymphopenia (Li, E.J.
(199) 221)
2-Methylserotonin
5-HT; receptors; Pain; Analgesia; Spinal cord (Giordano, J. (199) Nitric oxide (NO)
233) Aorta (rabbit); Platelet aggregation; Dipyridamole; Endothelium;
Organic nitrates (Bult, H. (199) 1)
Microdialysis
Ibogaine; Morphine; Dopamine; Striatum; Nucleus accumbens; Pre- N°-Nitro-L-arginine; Sympathetic nerve stimulation; Noradrenaline;
frontal cortex (Maisonneuve, I.M. (199) 35) Tail artery (rat) (Vo, P.A. (199) 123)
Dopamine D, receptor agonists; Dopamine release; Striatum; N-0437 Long-term potentiation; Hippocampus (rat); Synaptic plasticity
(2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin; N-0438 (2- (Bohme, G.A. (199) 379)
(N-propyl-N-2-thienylethylamino)-7-hydroxytetralin); 7-OH-DPAT
(7-hydroxy-2-(N,N-di-n-propylamino)tetralin); PHNO (4-propyl-9-hy-
Nitroglycerin
droxynaphthoxazine); (Stereoisomers) (Timmerman, W. (199) 145)
Norepinephrine; Norepinephrine release; Norepinephrine synthesis;
Norepinephrine turnover; Tyrosine hydroxylase; Cardiovascular ac-
Micturition
tion; Langendorff heart; Striatal slices (Ma, S. (199) 27)
Endothelins; Blood pressure; (Intracerebroventricular); (Rat) (Lecci,
A. (199) 201)
N©- Nitro-L-arginine
EDRF (endothelium-derived relaxing factor); L-Arginine; N°%-
N° -MonomethyI-L-arginine
Monomethyl-L-arginine; Vasoconstriction; Blood pressure (dog);
EDRF (endothelium-derived relaxing factor); L-Arginine; N°-Nitro-
Phenylephrine; Indomethacin; Coronary blood flow (Klabunde, R.E.
L-arginine; Vasoconstriction; Blood pressure (dog); Phenylephrine;
(199) 51)
Indomethacin; Coronary blood flow (Klabunde, R.E. (199) 51)
Nitric oxide (NO); Sympathetic nerve stimulation; Noradrenaline;
Morphine
Tail artery (rat) (Vo, P.A. (199) 123)
Ibogaine; Dopamine; Microdialysis; Striatum; Nucleus accumbens;
Prefrontal cortex (Maisonneuve, I.M. (199) 35)
[Lys?,Gly ®-R-y -lactam],N LKAe-(u3-?10 )
Neurokinin receptors; Iris (rabbit); Tachykinins; NK-1 receptors;
Myocardial blood flow (regional)
NK-3 receptors; Peptidase inhibitors; 5-Amino valeryl-[L-Pro’,N-
Dihydropyridine; $12968; Haemodynamics (systemic); Myocardial
Me-Leu!°]SP-; Senktide; (7-11) (Hall, J.M. (199) 9)
contractile function; Blood flow (regional); (Pig) (Sassen, L.M.A.
(199) 61)
NK-1 receptors
Myocardial contractile function Neurokinin receptors; Iris (rabbit); Tachykinins; NK-3 receptors;
Dihydropyridine; S$12968; Haemodynamics (systemic); Myocardial Peptidase inhibitors; 5-Amino valeryl-[L-Pro?,N-Me-Leu!°]SP-;
blood flow (regional); Blood flow (regional); (Pig) (Sassen, L.M.A. [Lys*,Gly®-R-y-lactam,Leu? INKA-(3-10); Senktide; (7-11) (Hall, J.M.
(199) 61) (199) 9)
Myometrium (rat) Tachykinins; Tachykinin receptor subtypes; Pulmonary artery (rab-
Bradykinin; B, receptor antagonists; Binding profiles; B, receptor bit); Trachea (hamster); (Competitive antagonists) (Maggi, C.A. (199)
subtypes (Liebmann, C. (199) 363) 127)